Abstract: Highlights•Proposed GINCM-DTA: a novel GIN model for DTA prediction with SOTA performance.•The fine-tuned GINCM-DTA achieved excellent performance: MSE=0.026, CI=0.967.•Identified Hydralazine as a potential inhibitor to block SARS-CoV-2 infection.•Potential effective against Omicron subvariants: BQ.1, BQ.1.1, XBB.1.5, XBB.1.16.•New computational strategy for COVID-19 antiviral screening & future virus epidemics.